Agenus (AGEN)

Agenus Stock News & Insights

LEXINGTON, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the appointment of Patricia Carlos as Chief Regulatory, Quality, and Safety Officer; Todd Yancey, MD as ...Read more

News Score - Last 7 Days

Sector Average
Media Buzz
This Week11 articles
Weekly Average9 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Healthcare Stocks that are Trending in the News
SHCSotera Health
VIRIVirios Therapeutics
RCKTRocket Pharmaceuticals
CLPTClearPoint Neuro
TBPHTheravance Biopharma
Showing the stocks with the most bullish news sentiment over the past week

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis